I am delighted to announce that Quinn Newcomb, has joined the Genome BC team as Executive Director, Corporate Development. This role works closely with other members of the management team… Read More
FDA Grants Rare Pediatric Disease Designation to XEN007 for Alternating Hemiplegia of Childhood (AHC); Xenon Eligible to Apply for Priority Review Voucher IND for XEN1101 Accepted; Site Selection and Patient… Read More
Takeda in Canada headed by General Manager Gamze Yüceland An expanded footprint positions Takeda to provide innovative treatments for Canadians with gastrointestinal illnesses, cancer, neurological conditions and rare diseases OAKVILLE, ON, Jan. 10, 2019 /CNW/… Read More
Agenus’ R&D Project Funded by Bill & Melinda Gates Foundation Employs PCF® Technology for Potent Vaccine Ingredient FORT WORTH, Texas, January 3, 2019 – Phyton Biotech today announced an exclusive… Read More
Vancouver, BC – Quark Venture Inc. (Quark) and GF Securities are pleased to announce their investment in Keros Therapeutics, a company dedicated to the discovery and development of novel therapeutics… Read More
